Expanded Agreement Gives St. Jude Medical Broader Use of SurModics' Cardiac Technologies

 

April 16, 2007

April 16, 2007 - SurModics Inc., a provider of surface modification and drug delivery technologies to the healthcare industry, announced the signing of an expanded corporate technology agreement with St. Jude Medical Inc.

Under the agreement, SurModics has licensed multiple technologies for use in products being developed in St. Jude Medical's Cardiovascular and Cardiac Rhythm Management divisions.

SurModics Inc.'s technologies include biocompatibility, site-specific drug delivery, biological cell encapsulation, and medical diagnostics.

For more information: www.surmodics.com.

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.